Exchange: NASDAQ·Updated 12:15 AM EDT
NRXP logo

NRXP NRX Pharmaceuticals Inc

$3.55
$0.00
(0.00%)
Overnight
Prev Close $3.55
Reported EarningsAug 17
Mkt Cap$153.7M
Vol695,596.00

About NRXP

NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C. Javitt on September 18, 2017 and is headquartered in Wilmington, DE.
35

Bearish Sentiment

How do you feel about NRXP?

Advertisement|Remove ads.